Preventing varicella-zoster disease
S Hambleton, AA Gershon - Clinical Microbiology Reviews, 2005 - Am Soc Microbiol
SUMMARY Varicella-zoster virus (VZV), the cause of chickenpox and shingles, is a
pathogen in retreat following the introduction of mass vaccination in the United States in …
pathogen in retreat following the introduction of mass vaccination in the United States in …
Epidemiology of varicella zoster virus infection in Canada and the United Kingdom
M Brisson, WJ Edmunds, B Law, NJ Gay… - Epidemiology & …, 2001 - cambridge.org
Many countries are currently studying the possibility of mass vaccination against varicella.
The objective of this study was to provide a comprehensive picture of the pre-vaccine …
The objective of this study was to provide a comprehensive picture of the pre-vaccine …
Modelling the impact of immunization on the epidemiology of varicella zoster virus
M Brisson, WJ Edmunds, NJ Gay, B Law… - Epidemiology & …, 2000 - cambridge.org
The objective of this study was to develop and apply a dynamic mathematical model of VZV
transmission to predict the effect of different vaccination strategies on the age-specific …
transmission to predict the effect of different vaccination strategies on the age-specific …
Successes and challenges in varicella vaccine
O Papaloukas, G Giannouli… - … advances in vaccines, 2014 - journals.sagepub.com
Varicella is a highly contagious disease caused by primary infection with varicella zoster
virus (VZV). VZV infection, as well as varicella vaccination, induces VZV-specific antibody …
virus (VZV). VZV infection, as well as varicella vaccination, induces VZV-specific antibody …
Economic burden of varicella in Europe in the absence of universal varicella vaccination
M Pawaskar, E Méroc, S Samant, E Flem, G Bencina… - BMC public health, 2021 - Springer
Background Though the disease burden of varicella in Europe has been reported
previously, the economic burden is still unknown. This study estimated the economic burden …
previously, the economic burden is still unknown. This study estimated the economic burden …
Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
J Hornberger, K Robertus - Annals of internal medicine, 2006 - acpjournals.org
Background: The Shingles Prevention Study showed that a varicella-zoster virus (VZV)
vaccine administered to adults 60 years of age or older reduced the incidence of herpes …
vaccine administered to adults 60 years of age or older reduced the incidence of herpes …
Varicella vaccination in England and Wales: cost-utility analysis
M Brisson, WJ Edmunds - Archives of disease in childhood, 2003 - adc.bmj.com
Aims: To assess the cost-effectiveness of varicella vaccination, taking into account its impact
on zoster. Methods: An age structured transmission dynamic model was used to predict the …
on zoster. Methods: An age structured transmission dynamic model was used to predict the …
Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs
M Brisson, WJ Edmunds - Medical decision making, 2006 - journals.sagepub.com
Guidelines for economic evaluations insist that the sensitivity of model results to alternative
parameter values should be thoroughly explored. However, differences in model …
parameter values should be thoroughly explored. However, differences in model …
Retrospective cost‐effectiveness analyses for polio vaccination in the United States
KM Thompson, RJD Tebbens - Risk Analysis, 2006 - Wiley Online Library
The history of polio vaccination in the United States spans 50 years and includes different
phases of the disease, multiple vaccines, and a sustained significant commitment of …
phases of the disease, multiple vaccines, and a sustained significant commitment of …